Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283158586> ?p ?o ?g. }
- W4283158586 endingPage "696" @default.
- W4283158586 startingPage "676" @default.
- W4283158586 abstract "Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for viral infections owing to characteristics such as their high specificity and their ability to enhance immune responses. Furthermore, antibody engineering can be used to strengthen effector function and prolong mAb half-life, and advances in structural biology have enabled the selection and optimization of potent neutralizing mAbs through identification of vulnerable regions in viral proteins, which can also be relevant for vaccine design. The COVID-19 pandemic has stimulated extensive efforts to develop neutralizing mAbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with several mAbs now having received authorization for emergency use, providing not just an important component of strategies to combat COVID-19 but also a boost to efforts to harness mAbs in therapeutic and preventive settings for other infectious diseases. Here, we describe advances in antibody discovery and engineering that have led to the development of mAbs for use against infections caused by viruses including SARS-CoV-2, respiratory syncytial virus (RSV), Ebola virus (EBOV), human cytomegalovirus (HCMV) and influenza. We also discuss the rationale for moving from empirical to structure-guided strategies in vaccine development, based on identifying optimal candidate antigens and vulnerable regions within them that can be targeted by antibodies to result in a strong protective immune response." @default.
- W4283158586 created "2022-06-21" @default.
- W4283158586 creator A5007165900 @default.
- W4283158586 creator A5015114088 @default.
- W4283158586 creator A5026870722 @default.
- W4283158586 creator A5037640677 @default.
- W4283158586 creator A5040838563 @default.
- W4283158586 date "2022-06-20" @default.
- W4283158586 modified "2023-10-18" @default.
- W4283158586 title "Antibodies to combat viral infections: development strategies and progress" @default.
- W4283158586 cites W1502725684 @default.
- W4283158586 cites W1522276317 @default.
- W4283158586 cites W1790889267 @default.
- W4283158586 cites W1816587284 @default.
- W4283158586 cites W1916620382 @default.
- W4283158586 cites W1933315991 @default.
- W4283158586 cites W1954458785 @default.
- W4283158586 cites W1968393246 @default.
- W4283158586 cites W1971742580 @default.
- W4283158586 cites W1974542809 @default.
- W4283158586 cites W1975876487 @default.
- W4283158586 cites W1976609017 @default.
- W4283158586 cites W1978036248 @default.
- W4283158586 cites W1979552897 @default.
- W4283158586 cites W1980322325 @default.
- W4283158586 cites W1980965429 @default.
- W4283158586 cites W1985322325 @default.
- W4283158586 cites W1985704471 @default.
- W4283158586 cites W1988459634 @default.
- W4283158586 cites W1988970665 @default.
- W4283158586 cites W1989275845 @default.
- W4283158586 cites W1989368177 @default.
- W4283158586 cites W1989676021 @default.
- W4283158586 cites W1992274022 @default.
- W4283158586 cites W1993928780 @default.
- W4283158586 cites W1996045402 @default.
- W4283158586 cites W1998383538 @default.
- W4283158586 cites W2001089308 @default.
- W4283158586 cites W2002632348 @default.
- W4283158586 cites W2004636952 @default.
- W4283158586 cites W2006840424 @default.
- W4283158586 cites W2011261569 @default.
- W4283158586 cites W2014442749 @default.
- W4283158586 cites W2014764918 @default.
- W4283158586 cites W2015193281 @default.
- W4283158586 cites W2018123062 @default.
- W4283158586 cites W2020430156 @default.
- W4283158586 cites W2024287923 @default.
- W4283158586 cites W2029345949 @default.
- W4283158586 cites W2030292647 @default.
- W4283158586 cites W2030522563 @default.
- W4283158586 cites W2032092033 @default.
- W4283158586 cites W2037382668 @default.
- W4283158586 cites W2038442395 @default.
- W4283158586 cites W2038838084 @default.
- W4283158586 cites W2039870425 @default.
- W4283158586 cites W2040299410 @default.
- W4283158586 cites W2043829974 @default.
- W4283158586 cites W2044326018 @default.
- W4283158586 cites W2044576882 @default.
- W4283158586 cites W2046587934 @default.
- W4283158586 cites W2048172399 @default.
- W4283158586 cites W2051184695 @default.
- W4283158586 cites W2051298245 @default.
- W4283158586 cites W2052277371 @default.
- W4283158586 cites W2052669763 @default.
- W4283158586 cites W2054392131 @default.
- W4283158586 cites W2056710036 @default.
- W4283158586 cites W2061059781 @default.
- W4283158586 cites W2066522660 @default.
- W4283158586 cites W2068359682 @default.
- W4283158586 cites W2070086938 @default.
- W4283158586 cites W2074361854 @default.
- W4283158586 cites W2074712481 @default.
- W4283158586 cites W2076251336 @default.
- W4283158586 cites W2076789803 @default.
- W4283158586 cites W2077219861 @default.
- W4283158586 cites W2082666550 @default.
- W4283158586 cites W2083637922 @default.
- W4283158586 cites W2090715236 @default.
- W4283158586 cites W2090763940 @default.
- W4283158586 cites W2092969802 @default.
- W4283158586 cites W2094048920 @default.
- W4283158586 cites W2094993149 @default.
- W4283158586 cites W2098497060 @default.
- W4283158586 cites W2102253058 @default.
- W4283158586 cites W2102686641 @default.
- W4283158586 cites W2104391453 @default.
- W4283158586 cites W2104515328 @default.
- W4283158586 cites W2108422942 @default.
- W4283158586 cites W2108573701 @default.
- W4283158586 cites W2109339916 @default.
- W4283158586 cites W2110287237 @default.
- W4283158586 cites W2116029690 @default.
- W4283158586 cites W2119111857 @default.
- W4283158586 cites W2120646408 @default.
- W4283158586 cites W2126114330 @default.
- W4283158586 cites W2127258151 @default.